Cerdanyola del Valles, Spain

Joaquin Arribas Lopez


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Joaquin Arribas Lopez: Innovator in Cancer Diagnosis and Therapy**

Introduction

Joaquin Arribas Lopez is a prominent inventor based in Cerdanyola del Valles, Spain. With a significant focus on advancements in cancer diagnosis and therapy, he holds two patents that contribute to the medical field, particularly concerning the HER2 receptor.

Latest Patents

Among Joaquin's notable patents, the first is related to "Antibodies against HER2 truncated variant CTF-611." This invention outlines a method for diagnosing and treating cancers expressing the HER2 receptor. It includes antibodies that specifically target an epitope of the HER2 receptor truncated form, CTF-611, allowing for distinction between various truncated forms of HER2. The second patent also focuses on a similar methodology for diagnosing cancers expressing the HER2 receptor or its truncated variants. Both inventions employ the detection of specific amino acid sequences in patient samples to facilitate accurate cancer diagnosis.

Career Highlights

Joaquin has accrued valuable experience through his work with esteemed institutions such as the Fundació Privada Institut De Recerca Hospital Universitari Vall Hebron and the Fundació Privada Institució Catalana De Recerca I Estudis Avancats. His research and innovations have significantly impacted cancer therapeutics and diagnostics, demonstrating his commitment to advancing medical science.

Collaborations

Throughout his career, Joaquin has collaborated with notable professionals, including Kim Pedersen and Pier-Davide Angellini. These partnerships have enhanced his research endeavors and fostered innovative solutions in the field of cancer treatment.

Conclusion

Joaquin Arribas Lopez exemplifies the spirit of innovation, particularly in the realm of cancer research. His contributions through patents that focus on HER2 receptor-targeting antibodies play a crucial role in the future of cancer diagnosis and therapy. As medical research continues to evolve, the impact of inventors like Joaquin will undoubtedly pave the way for advancements that can improve patient outcomes and enhance the understanding of complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…